Platform
Features
Pricing
0 followers
Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.
Industries
Headquarters
Employees
Links
Full screen
Torsten Mummenbrauer
View all
9 people · 0 jobs
5 people · 0 jobs
4 people · 0 jobs
2 people · 0 jobs
HQ
7 positions, 0 job posts
Galapagos
4 followers
Merck
277 followers
Amgen
273 followers
Pierre Fabre
15 followers
Revvity
8 followers
AtriCure
QuellTX
Abbott
372 followers
Sanofi
279 followers
Gilead Sciences
157 followers
Regeneron
124 followers
Explore companies